October 8, 2024
Optinose Appoints Terry Kohler as Chief Financial Officer
YARDLEY, Pa., Oct. 07, 2024 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose…
Pharmaceuticals, Biotechnology and Life Sciences
YARDLEY, Pa., Oct. 07, 2024 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose…
QIAGEN’s leading tuberculosis blood test QuantiFERON®-TB Gold Plus remains crucial for detection of latent tuberculosis infection, aiding in breaking the…
VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the…
[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05,…
— OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in…
Strengthens balance sheet with non-dilutive capital to enable further pipeline development and related strategic prioritiesCAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE…
CINCINATTI, OH., Oct. 03, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Onconetix,…
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and…
IRVINE, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in…
– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct.…